At present, we only know the BAP1 tumor predisposition syndrome, and this syndrome comprises only an insignificant fraction of the patients with accumulated cancers in our series, in accordance with a 3% occurrence of BAP1 variants in patients with posterior UM [9]. This evidence concerns the gene BAP1 and BAP1-related tumor predisposition syndrome.